Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Work In Process (2016 - 2022)

Biomerica's Work In Process history spans 11 years, with the latest figure at $714000.0 for Q1 2022.

  • For Q1 2022, Work In Process fell 27.81% year-over-year to $714000.0; the TTM value through Feb 2022 reached $714000.0, down 27.81%, while the annual FY2021 figure was $1.0 million, 1.82% up from the prior year.
  • Work In Process for Q1 2022 was $714000.0 at Biomerica, up from $708000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $1.5 million in Q4 2020 and bottomed at $708000.0 in Q4 2021.
  • The 5-year median for Work In Process is $872000.0 (2018), against an average of $904625.0.
  • The largest annual shift saw Work In Process skyrocketed 81.56% in 2020 before it tumbled 53.3% in 2021.
  • A 5-year view of Work In Process shows it stood at $791000.0 in 2018, then rose by 5.56% to $835000.0 in 2019, then surged by 81.56% to $1.5 million in 2020, then crashed by 53.3% to $708000.0 in 2021, then increased by 0.85% to $714000.0 in 2022.
  • Per Business Quant, the three most recent readings for BMRA's Work In Process are $714000.0 (Q1 2022), $708000.0 (Q4 2021), and $926000.0 (Q3 2021).